Muromonab-CD3 - History

History

Muromonab-CD3 (OKT3) was approved by the U.S. Food and Drug Administration (FDA) in 1986, making it the first monoclonal antibody to be approved anywhere as a drug for humans. In the European Communities, it was the first drug to be approved under the directive 87/22/EWG, a precursor of the European Medicines Agency (EMEA) centralised approval system in the European Union. This process included an assessment by the Committee for Proprietary Medicinal Products (CPMP, now CHMP), and a subsequent approval by the national health agencies; in Germany, for example, in 1988 by the Paul Ehrlich Institute in Frankfurt. However, the manufacturer of Muromonab-CD3 has voluntarily withdrawn it from the United States market due to decreased utilization; current OKT3 supplies are expected to be exhausted by mid-2010.

Read more about this topic:  Muromonab-CD3

Famous quotes containing the word history:

    No cause is left but the most ancient of all, the one, in fact, that from the beginning of our history has determined the very existence of politics, the cause of freedom versus tyranny.
    Hannah Arendt (1906–1975)

    In every election in American history both parties have their clichés. The party that has the clichés that ring true wins.
    Newt Gingrich (b. 1943)

    Like their personal lives, women’s history is fragmented, interrupted; a shadow history of human beings whose existence has been shaped by the efforts and the demands of others.
    Elizabeth Janeway (b. 1913)